Free Trial

Corteva (CTVA) Stock Forecast & Price Target

Corteva logo
$69.13 +0.32 (+0.47%)
As of 05/20/2025 03:58 PM Eastern

Corteva - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
3
Buy
12

Based on 16 Wall Street analysts who have issued ratings for Corteva in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 1 has given a sell rating, 3 have given a hold rating, and 12 have given a buy rating for CTVA.

Consensus Price Target

$70.50
1.98% Upside
According to the 16 analysts' twelve-month price targets for Corteva, the average price target is $70.50. The highest price target for CTVA is $79.00, while the lowest price target for CTVA is $55.00. The average price target represents a forecasted upside of 1.98% from the current price of $69.13.
Get the Latest News and Ratings for CTVA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Corteva and its competitors.

Sign Up

CTVA Analyst Ratings Over Time

TypeCurrent Forecast
5/21/24 to 5/21/25
1 Month Ago
4/21/24 to 4/21/25
3 Months Ago
2/21/24 to 2/20/25
1 Year Ago
5/22/23 to 5/21/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
12 Buy rating(s)
14 Buy rating(s)
13 Buy rating(s)
16 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
6 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$70.50$68.13$67.73$63.24
Forecasted Upside1.98% Upside15.06% Upside6.21% Upside11.63% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

CTVA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CTVA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Corteva Stock vs. The Competition

TypeCortevaConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.69
2.54
2.54
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside1.98% Upside48.27% Upside13.03% Upside
News Sentiment Rating
Positive News

See Recent CTVA News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/14/2025Barclays
3 of 5 stars
Benjamin Theurer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$64.00 ➝ $70.00+4.52%
5/12/2025Wells Fargo & Company
3 of 5 stars
Richard Garchitorena
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$73.00 ➝ $79.00+16.75%
5/9/2025Oppenheimer
3 of 5 stars
Kristen Owen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$72.00 ➝ $75.00+11.05%
5/9/2025Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Patrick Cunningham
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$75.00 ➝ $78.00+15.86%
5/9/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Vincent Andrews
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$65.00 ➝ $71.00+5.47%
5/9/2025KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Aleksey Yefremov
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$71.00 ➝ $72.00+7.49%
5/8/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Joshua Spector
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$74.00 ➝ $76.00+14.17%
3/31/2025Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Bill Selesky
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$69.00 ➝ $69.00+12.96%
3/13/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Duffy Fischer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$71.00+20.19%
2/11/2025Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Steve Byrne
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$69.00 ➝ $73.00+17.36%
2/10/2025BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
L. Favre
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
2/7/2025Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Arun Viswanathan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$72.00 ➝ $73.00+17.09%
8/2/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$57.00 ➝ $55.00+6.63%
6/18/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$61.00 ➝ $60.00+15.27%
6/12/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$65.00 ➝ $65.00+25.90%
6/7/2024OTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMixed ➝ Negative
5/3/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$60.00 ➝ $65.00+13.72%
5/3/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$64.00 ➝ $67.00+17.13%
3/1/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$67.00+25.30%
2/12/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$57.00 ➝ $65.00+21.27%
11/27/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$63.00 ➝ $52.00+11.42%
11/22/2023Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$82.00 ➝ $63.00+36.45%
8/4/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$74.00+31.95%
7/25/2023Redburn Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
5/22/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingUpgrade
5/22/2023Vertical Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$67.00+17.61%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 04:00 AM ET.


Should I Buy Corteva Stock? CTVA Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, May 16, 2025. Please send any questions or comments about these Corteva pros and cons to contact@marketbeat.com.

Corteva
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Corteva, Inc.:

  • The company recently reported earnings per share (EPS) of $1.13, exceeding analysts' expectations, which indicates strong financial performance and potential for growth.
  • Corteva, Inc. has a current stock price around $68, reflecting a stable market position and potential for appreciation based on recent analyst upgrades.
  • Analysts have shown confidence in Corteva, with multiple upgrades to "buy" ratings and increased price targets, suggesting a positive outlook for the stock.
  • The company declared a quarterly dividend of $0.17 per share, providing a return on investment for shareholders and indicating financial health.
  • Corteva operates in the agriculture sector, which is essential and resilient, providing a steady demand for its products even in fluctuating market conditions.

Corteva
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Corteva, Inc. for these reasons:

  • Despite strong earnings, Corteva's revenue for the quarter was down compared to the same period last year, indicating potential challenges in maintaining growth.
  • The company's net margin is relatively low at 5.36%, which may limit profitability and investor returns compared to competitors with higher margins.
  • Insider selling activity has been noted, with significant shares sold by an insider, which could signal a lack of confidence in the company's future performance.
  • The stock has a high price-to-earnings (P/E) ratio, suggesting it may be overvalued compared to its earnings, which could deter value-focused investors.
  • Market volatility and economic uncertainties can impact the agriculture sector, potentially affecting Corteva's performance and stock price.

CTVA Forecast - Frequently Asked Questions

According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Corteva is $70.50, with a high forecast of $79.00 and a low forecast of $55.00.

16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Corteva in the last twelve months. There is currently 1 sell rating, 3 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CTVA shares.

According to analysts, Corteva's stock has a predicted upside of 1.98% based on their 12-month stock forecasts.

Over the previous 90 days, Corteva's stock had 1 upgrade by analysts.

Corteva has been rated by research analysts at Argus, Barclays, Citigroup, KeyCorp, Morgan Stanley, Oppenheimer, The Goldman Sachs Group, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Corteva more than other "consumer staples" companies. The consensus rating score for Corteva is 2.69 while the average consensus rating score for "consumer staples" companies is 2.54. Learn more on how CTVA compares to other companies.


This page (NYSE:CTVA) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners